Eating healthy over the summer is vital with liver disease
Vacation is all most of us ever want after slogging through spring’s yearning and the early promise of a great summer. We fly to foreign…
Fatty liver disease
Pemvidutide shows benefit for MASH in Phase 2b clinical trial
Pemvidutide resolved metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease, without worsening liver scarring (fibrosis) for more than half of people…
Taking your liver to work: Managing MASH on the job
As I sat down to write this week’s column, my imagination flipped on its silly switch. I couldn’t help but picture a sick cartoon liver…
EMA committee supports Rezdiffra’s OK for fatty liver disease MASH
A committee of the European Medicines Agency (EMA) has granted a positive opinion to Rezdiffra (resmetirom) to treat some people with metabolic dysfunction-associated steatohepatitis (MASH),…
Why you should regularly review your list of medications
When I started getting sicker from metabolic dysfunction-associated steatohepatitis (MASH), doctors prescribed several medications to manage my symptoms and, hopefully, prevent further damage.
Diabetes drug dapagliflozin shows benefits for MASH in Phase 3 trial
Daily treatment with the diabetes medication dapagliflozin eased disease severity for people with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease,…
How my knees and liver taught me to heal my whole body
Last week marked one of the two times each year when I see most of my doctors to check on my ailing liver. I call…
Scientists call for more efforts to diagnose liver disease MASH
An international team of scientists called for more efforts to diagnose metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease, arguing that…
Special de-liver-y: How ordering groceries has helped my fatty liver
Every week, like clockwork, I ask my daughter to give me her list of foods she’d like for the week. Since I’ve given up having…
Fatty liver disease MASLD to affect 16% of teens, young adults by 2050
The total number of adolescents and young adults with metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty liver disease, has been steadily…
